Clorox
CLX | NYSE
$85.24
+$2.14 (+2.58%)
Sep 21, 2026, 1:56 PM ET · Market open
Fiscal Year Period Ending | FY 2026 Jun 29, 2026 | FY 2025 Jun 29, 2025 | FY 2024 Jun 29, 2024 | FY 2023 Jun 29, 2023 | FY 2022 Jun 29, 2022 | FY 2021 Jun 29, 2021 |
|---|---|---|---|---|---|---|
Revenue | 6.72B | 7.1B | 7.09B | 7.39B | 7.11B | 7.34B |
Cost of Revenue | 3.88B | 3.89B | 4.05B | 4.48B | 4.56B | 4.14B |
Gross Profit | 2.84B | 3.21B | 3.05B | 2.91B | 2.55B | 3.2B |
Operating Income | 1.66B | 1.18B | 723M | 823M | 719M | 1.23B |
Interest Income | 8M | 9M | 23M | 16M | 5M | 5M |
Pretax Income | 791M | 1.08B | 398M | 238M | 607M | 900M |
Net Income | 587M | 810M | 280M | 149M | 462M | 710M |
Selling & General & Admin | 1.07B | 1.89B | 2.17B | 1.92B | 1.66B | 1.79B |
Research & Development | 116M | 121M | 126M | 138M | 132M | 149M |
Other Expenses | n/a | 21M | 29M | 30M | 31M | 31M |
Operating Expenses | 1.18B | 2.04B | 2.33B | 2.09B | 1.83B | 1.97B |
Interest Expense | 130M | 88M | 90M | 90M | 106M | 99M |
Selling & Marketing Expenses | 749M | 770M | 832M | 734M | 709M | 790M |
Cost & Expenses | 5.06B | 5.93B | 6.37B | 6.57B | 6.39B | 6.12B |
Income Tax Expense | 190M | 254M | 106M | 77M | 136M | 181M |
Shares Outstanding (Basic) | 121.78M | 123.53M | 124.17M | 123.59M | 123.11M | 125.57M |
Shares Outstanding (Diluted) | 122.13M | 124.29M | 124.8M | 124.18M | 123.91M | 127.3M |
EPS (Basic) | 4.82 | 6.56 | 2.25 | 1.21 | 3.75 | 5.65 |
EPS (Diluted) | 4.81 | 6.52 | 2.25 | 1.20 | 3.73 | 5.58 |
EBITDA | 921M | 1.39B | 723M | 564M | 937M | 1.21B |
EBIT | 921M | 1.17B | 488M | 328M | 713M | 999M |
Depreciation & Amortization | n/a | 219M | 235M | 236M | 224M | 211M |
Add to Watchlist
Select watchlists to add or remove CLX